BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 33491760)

  • 1. Aspirin inhibits cholangiocarcinoma cell proliferation via cell cycle arrest in vitro and in vivo.
    Shi T; Gong J; Fujita K; Nishiyama N; Iwama H; Liu S; Nakahara M; Yoneyama H; Morishita A; Nonura T; Kobara H; Okano K; Suzuki Y; Masaki T
    Int J Oncol; 2021 Feb; 58(2):199-210. PubMed ID: 33491760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin receptor blocker telmisartan inhibits cell proliferation and tumor growth of cholangiocarcinoma through cell cycle arrest.
    Samukawa E; Fujihara S; Oura K; Iwama H; Yamana Y; Tadokoro T; Chiyo T; Kobayashi K; Morishita A; Nakahara M; Kobara H; Mori H; Okano K; Suzuki Y; Himoto T; Masaki T
    Int J Oncol; 2017 Dec; 51(6):1674-1684. PubMed ID: 29075786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-551b-3p inhibits tumour growth of human cholangiocarcinoma by targeting Cyclin D1.
    Chang W; Wang Y; Li W; Shi L; Geng Z
    J Cell Mol Med; 2019 Aug; 23(8):4945-4954. PubMed ID: 31199052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspirin inhibits hepatocellular carcinoma cell proliferation in vitro and in vivo via inducing cell cycle arrest and apoptosis.
    Shi T; Fujita K; Gong J; Nakahara M; Iwama H; Liu S; Yoneyama H; Morishita A; Nomura T; Tani J; Takuma K; Tadokoro T; Himoto T; Oura K; Tsutsui K; Kobara H; Masaki T
    Oncol Rep; 2020 Aug; 44(2):457-468. PubMed ID: 32627038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FTY720 inhibits proliferation and epithelial-mesenchymal transition in cholangiocarcinoma by inactivating STAT3 signaling.
    Lu Z; Wang J; Zheng T; Liang Y; Yin D; Song R; Pei T; Pan S; Jiang H; Liu L
    BMC Cancer; 2014 Oct; 14():783. PubMed ID: 25344679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA myocardial infarction associated transcript promotes the proliferation of cholangiocarcinoma cells by targeting miR-551b-3p/CCND1 axis.
    Chang W; Wang Y; Li W; Geng Z
    Clin Exp Pharmacol Physiol; 2020 Jun; 47(6):1067-1075. PubMed ID: 32064660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of l-type amino acid transporter 1 activity as a new therapeutic target for cholangiocarcinoma treatment.
    Yothaisong S; Dokduang H; Anzai N; Hayashi K; Namwat N; Yongvanit P; Sangkhamanon S; Jutabha P; Endou H; Loilome W
    Tumour Biol; 2017 Mar; 39(3):1010428317694545. PubMed ID: 28347255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cyclin‑dependent kinase pathway involving CDK1 is a potential therapeutic target for cholangiocarcinoma.
    Yamamura M; Sato Y; Takahashi K; Sasaki M; Harada K
    Oncol Rep; 2020 Jan; 43(1):306-317. PubMed ID: 31746435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin potentiates the anticancer activities of gemcitabine and cisplatin against cholangiocarcinoma cells in vitro and in vivo.
    Zhu HQ; Ma JB; Song X; Gao HJ; Ma CQ; Chang H; Li HG; Liu FF; Lu J; Zhou X
    Oncol Rep; 2016 Dec; 36(6):3488-3496. PubMed ID: 27779693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cryptotanshinone induces cell cycle arrest and apoptosis through the JAK2/STAT3 and PI3K/Akt/NFκB pathways in cholangiocarcinoma cells.
    Ke F; Wang Z; Song X; Ma Q; Hu Y; Jiang L; Zhang Y; Liu Y; Zhang Y; Gong W
    Drug Des Devel Ther; 2017; 11():1753-1766. PubMed ID: 28670110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A inhibits the growth of cholangiocarcinoma cells.
    Nakagawa S; Sakamoto Y; Okabe H; Hayashi H; Hashimoto D; Yokoyama N; Tokunaga R; Sakamoto K; Kuroki H; Mima K; Beppu T; Baba H
    Oncol Rep; 2014 Feb; 31(2):983-8. PubMed ID: 24337160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of FOXO4 Inhibits Cholangiocarcinoma Cell Proliferation
    Intuyod K; Chomwong S; Thongpon P; Vaeteewoottacharn K; Pairojkul C; Pinlaor P; Pinlaor S
    Anticancer Res; 2020 Dec; 40(12):6899-6905. PubMed ID: 33288583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptosis-related protein-1 acts as a tumor suppressor in cholangiocarcinoma cells by inducing cell cycle arrest via downregulation of cyclin-dependent kinase subunits.
    Zheng J; Li Q; Wang W; Wang Y; Fu X; Wang W; Fan L; Yan W
    Oncol Rep; 2016 Feb; 35(2):809-16. PubMed ID: 26572808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lobaplatin induces apoptosis and arrests cell cycle progression in human cholangiocarcinoma cell line RBE.
    Wang Z; Tang X; Zhang Y; Qi R; Li Z; Zhang K; Liu Z; Yang X
    Biomed Pharmacother; 2012 Apr; 66(3):161-6. PubMed ID: 22425181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formononetin promotes cell cycle arrest via downregulation of Akt/Cyclin D1/CDK4 in human prostate cancer cells.
    Li T; Zhao X; Mo Z; Huang W; Yan H; Ling Z; Ye Y
    Cell Physiol Biochem; 2014; 34(4):1351-8. PubMed ID: 25301361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anlotinib suppresses tumor progression via blocking the VEGFR2/PI3K/AKT cascade in intrahepatic cholangiocarcinoma.
    Song F; Hu B; Cheng JW; Sun YF; Zhou KQ; Wang PX; Guo W; Zhou J; Fan J; Chen Z; Yang XR
    Cell Death Dis; 2020 Jul; 11(7):573. PubMed ID: 32709873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene and microRNA modulation upon trabectedin treatment in a human intrahepatic cholangiocarcinoma paired patient derived xenograft and cell line.
    Peraldo Neia C; Cavalloni G; Chiorino G; Ostano P; Aglietta M; Leone F
    Oncotarget; 2016 Dec; 7(52):86766-86780. PubMed ID: 27902465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual blockade of the Hedgehog and ERK1/2 pathways coordinately decreases proliferation and survival of cholangiocarcinoma cells.
    Jinawath A; Akiyama Y; Sripa B; Yuasa Y
    J Cancer Res Clin Oncol; 2007 Apr; 133(4):271-8. PubMed ID: 17294242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-34a-dependent overexpression of Per1 decreases cholangiocarcinoma growth.
    Han Y; Meng F; Venter J; Wu N; Wan Y; Standeford H; Francis H; Meininger C; Greene J; Trzeciakowski JP; Ehrlich L; Glaser S; Alpini G
    J Hepatol; 2016 Jun; 64(6):1295-304. PubMed ID: 26923637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-211 suppresses epithelial ovarian cancer proliferation and cell-cycle progression by targeting Cyclin D1 and CDK6.
    Xia B; Yang S; Liu T; Lou G
    Mol Cancer; 2015 Mar; 14():57. PubMed ID: 25889927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.